Clinical Edge Journal Scan

Increased Burden of Headache and Migraine in PsA Patients


 

Key clinical point: Compared with control individuals without psoriatic arthritis (PsA), the burden of headache and migraine without aura was significantly higher in patients with PsA.

Major finding: The prevalence of headache (39.81% vs 26.44%; P = .028) and migraine without aura (18.52% vs 9.2%; P = .044) was significantly higher in patients with PsA vs control individuals without PsA. Patients with PsA who did vs did not have headaches also presented with a higher burden of comorbidities and prevalence of enthesitis (P = .02 for both).

Study details: This cross-sectional, observational cohort study included 216 patients with PsA, 70 patients with axial spondyloarthritis, and 87 gender-matched control individuals.

Disclosures: This study did not receive any external funding. The authors declared no conflicts of interest.

Source: Marino A, Currado D, Altamura C, et al. Increased prevalence of headaches and migraine in patients with psoriatic arthritis and axial spondyloarthritis: Insights from an Italian cohort study. Biomedicines. 2024;12(2):371. doi: 10.3390/biomedicines12020371 Source

Recommended Reading

Pretreatment Lab Testing for Chronic Skin Diseases Diverges From Guidelines
MDedge Rheumatology
Vascular Inflammation is Increased in Patients with PsA
MDedge Rheumatology
Neuropathic Pain May Increase Disease Burden in PsA
MDedge Rheumatology
Upadacitinib Offers Enthesitis Resolution in PsA
MDedge Rheumatology
Meta-analysis Confirms Promising Efficacy-Safety Profile of Risankizumab in PsA
MDedge Rheumatology
Tofacitinib Effective Across Multiple PsA Domains in The Real World
MDedge Rheumatology
Lower Prevalence of Psychotic Disorders in Patients with PsA
MDedge Rheumatology
Serum Biomarkers Identifying Guselkumab Responders Among TNFi-Inadequate Responders with PsA
MDedge Rheumatology
Two or More Morbidities at Psoriasis Onset May Indicate Increased PsA Risk
MDedge Rheumatology
Etanercept Effective and Safe in PsA Patients in the Real-World
MDedge Rheumatology